Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
RESOURCE LINE
VACCINE
September/October 2009
Protecting Canadian adults from vaccine-preventable diseases: NACI recommendations Parkins et al. Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary...
PRIORITY PRESS - 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Addressing Emerging Pneumococcal Serotypes with a 13-Valent Vaccine
San Francisco, California / September 12-15, 2009
San Francisco - The reduction in morbidity and mortality associated with the 7-valent pneumococcal conjugate vaccine (PCV7) is expected to be extended substantially with the advent of a new conjugate vaccine that targets six additional...
PRIORITY PRESS - 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Therapeutic Drug Monitoring Emerging as Standard of Care for Selected Antifungals
San Francisco, California / September 12-15, 2009
San Francisco - Due to interpatient variability in the pharmacokinetics and pharmacodynamics of the azole antifungal agents, a strong emphasis is now being placed on therapeutic drug monitoring for most of the newer agents in this class....
PRIORITY PRESS - 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Long-Term Data Associate CCR5-Inhibitors with Encouraging Tolerability Profile
San Francisco, California / September 12-15, 2009
Efficacy was once the single most important criterion for evaluating antiretroviral therapies (ARTs) because of the limited treatment options and the potential for a fatal outcome when HIV control could not be sustained. However, there is...
PRIORITY PRESS - 5th International Conference on Vaccines for Enteric Diseases
Global Health Implications of the Rotavirus Vaccine
Málaga, Spain / September 9-11, 2009
Málaga - Two rotavirus (RV) vaccines are currently available worldwide. In clinical trials using European, North American and South American populations, both have demonstrated 90% to 100% efficacy in preventing severe RV gastroenteritis...
RESOURCE LINE
MRSA
Autumn 2009
Kitchens, bathrooms highly contaminated with MRSA and other pathogens Scott et al. A critical evaluation of methicillin-resistant Staphylococcus aureus and other bacteria of medical interest on commonly touched household surfaces...
RESOURCE LINE
VACCINE
July/August 2009
Vaccination against high-risk HPV types to reduce lesions and cervical cancer Moore et al. Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccination. Cancer Causes Control...
PRIORITY PRESS - Fifth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention
Chronic Control of HIV from the Perspective of Quality of Life
Cape Town, South Africa / July 19-22, 2009
History of the ARV Arsenal So far, the pace of antiretroviral drug development has not only been adequate to provide most patients who have multiple-drug resistant HIV with options but to identify highly active antiretroviral therapy...
NEW FRONTIERS - Fifth International AIDS Society (IAS)
Goals of HIV Control in Aging Populations
Cape Town, South Africa / July 19-22, 2009
More than 10 years after highly active antiretroviral therapy (HAART) transformed HIV from an almost inevitably fatal disease into a chronic infection, the average age of patients with HIV has shifted upwards, placing an increasing...